| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3996970 | Practical Radiation Oncology | 2014 | 9 Pages |
Abstract
In endometrial cancer, the use of IMRT for dose escalation to gross nodal disease is feasible with acceptable rates of toxicity. Patients with nodal recurrence or unresectable nodal disease after a hysterectomy may benefit from radiation dose escalation.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kanokpis MD, Philip D. MD, Antonio L. PhD, Rebecca BA, Larissa J. MD, Suzanne DO, Colleen MD, Akila N. MD MPH,